AAAAAA
Results:
1-19
|
Results: 19
Authors:
BROOKS SP
BERNSTEIN ZP
SCHNEIDER SL
GOLLNICK SO
TOMASI TB
Citation: Sp. Brooks et al., RECOVERY OF ACCESSORY CELL-FUNCTION IN HIV-INFECTED PATIENTS WITH AIDS-RELATED MALIGNANCIES FOLLOWING INFUSION WITH GM CSF, The FASEB journal, 12(4), 1998, pp. 1723-1723
Authors:
BERNSTEIN ZP
YUCHI S
BATTISTA E
LEMA M
SPAULDING MB
Citation: Zp. Bernstein et al., PROGLUMIDE AS A MORPHINE ADJUNCT IN CANCER PAIN MANAGEMENT, Journal of pain and symptom management, 15(5), 1998, pp. 314-320
Authors:
BROOKS SP
BERNSTEIN ZP
SCHNEIDER SL
GOLLNICK SO
TOMASI TB
Citation: Sp. Brooks et al., ROLE OF TRANSFORMING GROWTH-FACTOR-BETA-1 IN THE SUPPRESSED ALLOSTIMULATORY FUNCTION OF AIDS PATIENTS, AIDS, 12(5), 1998, pp. 481-487
Authors:
FEHNIGER TA
HERBEIN G
YU HX
PARA MI
BERNSTEIN ZP
OBRIEN WA
CALIGIURI MA
Citation: Ta. Fehniger et al., NATURAL-KILLER-CELLS FROM HIV-1(-C CHEMOKINES AND INHIBIT HIV-1 INFECTION() PATIENTS PRODUCE C), The Journal of immunology (1950), 161(11), 1998, pp. 6433-6438
Authors:
KHATRI VP
FEHNIGER TA
BAIOCCHI RA
YU F
SHAH MH
SCHILLER DS
GOULD M
GAZZINELLI RT
BERNSTEIN ZP
CALIGIURI MA
Citation: Vp. Khatri et al., ULTRA-LOW DOSE INTERLEUKIN-2 THERAPY PROMOTES A TYPE-1 CYTOKINE PROFILE IN-VIVO IN PATIENTS WITH AIDS AND AIDS-ASSOCIATED MALIGNANCIES, The Journal of clinical investigation, 101(6), 1998, pp. 1373-1378
Authors:
KHATRI VP
BAIOCCHI RA
BERNSTEIN ZP
CALIGIURI MA
Citation: Vp. Khatri et al., IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 - RATIONALE FOR PREVENTION OF IMMUNE-DEFICIENCY-ASSOCIATED CANCER, The cancer journal from Scientific American, 3, 1997, pp. 128-136
Authors:
BERNSTEIN ZP
COHEN P
RIOS A
WAGNER B
FISCHL M
GROOPMAN J
BOCK A
GILL P
Citation: Zp. Bernstein et al., A MULTICENTER, PHASE II III STUDY OF ATRAGEN(TM) (TRETINOIN LIPOSOMAL) IN PATIENTS WITH AIDS-ASSOCIATED KAPOSIS-SARCOMA/, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 14-14
Authors:
BERNSTEIN ZP
BARRESI G
GOULD M
POIESZ B
CALIGIURI MA
Citation: Zp. Bernstein et al., A PHASE-II STUDY OF DAILY SUBCUTANEOUS (SQ) LOW-DOSE INTERLEUKIN-2 (IL-2) IN HIV-ASSOCIATED MALIGNANCIES, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 96-96
Authors:
KHATRI VP
YU F
BAIOCCHI RA
SHAH MH
ZWERLING BH
GOULD M
BERNSTEIN ZP
CALIGIURI MA
Citation: Vp. Khatri et al., ANALYSIS OF T(H)1 T(H)2 CYTOKINE GENE PROFILE DURING LOW-DOSE IL-2 THERAPY IN PATIENTS WITH AIDS OR AIDS LYMPHOMA/, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 99-99
Authors:
KHATRI VP
BAIOCCHI RA
BERNSTEIN ZP
CALIGIURI MA
Citation: Vp. Khatri et al., LYMPHOMAGENESIS IN THE SEVERE COMBINED IMMUNE-DEFICIENT MOUSE ENGRAFTED WITH HUMAN-LYMPHOCYTES - CLUES TOWARDS THE PATHOGENESIS AND TREATMENT OF AIDS LYMPHOMA (REVIEW), Oncology Reports, 4, 1997, pp. 241-246
Authors:
BAIOCCHI RA
KHATRI VP
LINDEMANN MJ
ROSS ME
PAPOFF G
CAPRIO AJ
CAPRIO TV
FENSTERMAKER R
RUBERTI G
BERNSTEIN ZP
CALIGIURI MA
Citation: Ra. Baiocchi et al., PHENOTYPIC AND FUNCTIONAL-ANALYSIS OF FAS (CD95) EXPRESSION IN PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA OF PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Blood, 90(5), 1997, pp. 1737-1746
Authors:
BERNSTEIN ZP
BROOKS S
HAYES FA
GOULD M
JACOB S
TOMASI TB
Citation: Zp. Bernstein et al., A PILOT-STUDY IN THE USE OF GM-CSF IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTED INDIVIDUALS, Blood, 90(10), 1997, pp. 584-584
Authors:
BERNSTEIN ZP
GOULD M
JACOB S
Citation: Zp. Bernstein et al., CYTOSINE-ARABINOSIDE, ADRIAMYCIN, CISPLATIN, DECADRON, HYDROXYUREA, DDI AND INTERLEUKIN-2 (IL-2) FOR HIV-ASSOCIATED LYMPHOMA, A PILOT-STUDY, Blood, 90(10), 1997, pp. 1526-1526
Authors:
BERNSTEIN ZP
BROOKS SP
GOLLNICK SO
SCHNEIDER SS
TOMASI T
Citation: Zp. Bernstein et al., TREATMENT OF AIDS PATIENTS WITH GM-CSF POTENTIATES ACCESSORY CELL-FUNCTION, Blood, 88(10), 1996, pp. 2869-2869
Authors:
BAIOCCHI RA
KHATRI V
LINDEMANN MI
ROSS ME
CAPRIO AI
CAPRIO TV
FENSTERMAKER R
BERNSTEIN ZP
CALIGIURI MA
Citation: Ra. Baiocchi et al., ANALYSIS OF FAS CD95 EXPRESSION AND FUNCTION IN EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED HUMAN B-CELL TUMORS/, Blood, 88(10), 1996, pp. 1509-1509
Authors:
BERNSTEIN ZP
PORTER MM
GOULD M
LIPMAN B
BLUMAN EM
STEWART CC
HEWITT RG
FYFE G
POIESZ B
CALIGIURI MA
Citation: Zp. Bernstein et al., PROLONGED ADMINISTRATION OF LOW-DOSE INTERLEUKIN-2 IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED MALIGNANCY RESULTS IN SELECTIVE EXPANSION OF INNATE IMMUNE EFFECTORS WITHOUT SIGNIFICANT CLINICAL TOXICITY, Blood, 86(9), 1995, pp. 3287-3294
Authors:
BLOCK AW
LAUDICO TJ
OLSON JM
DADEY B
HENDERSON ES
HAN T
BERNSTEIN ZP
Citation: Aw. Block et al., TRISOMY-12 IN CHRONIC LYMPHOCYTIC-LEUKEMIA - DETECTION OF LOW-LEVELS OF -FLUORESCENCE IN-SITU(12), Blood, 86(10), 1995, pp. 3306-3306
Authors:
BERNSTEIN ZP
PORTER M
GRIMES P
GOULD M
POIESZ B
FYFE G
CALIGIURI MA
Citation: Zp. Bernstein et al., PHASE-I STUDY OF DAILY SUBCUTANEOUS (SQ) LOW-DOSE INTERLEUKIN-2 (IL-2) IN HIV-ASSOCIATED MALIGNANCIES, Blood, 84(10), 1994, pp. 10000483-10000483
Authors:
FOON KA
THIRUVENGADAM R
SAVEN A
BERNSTEIN ZP
GALE RP
Citation: Ka. Foon et al., GENETIC RELATEDNESS OF LYMPHOID MALIGNANCIES - TRANSFORMATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA AS A MODEL, Annals of internal medicine, 119(1), 1993, pp. 63-73
Risultati:
1-19
|